Stephanie J. Nahas, MD

Director, Headache Medicine Fellowship Program, Associate Professor, Thomas Jefferson University

Articles by Stephanie J. Nahas, MD

Discussing Preventative Migraine Lifestyle Changes with Patients

ByJessica Ailani, MD,Christopher Gottschalk, MD,Stephanie J. Nahas, MD,Rebecca Erwin Wells, MD, MPH,Andrew C. Charles, MD

December 3rd 2021

Dr Andrew Charles shares how he eases patient anxieties over lifestyle changes for preventive migraine therapy.

Non-Drug Therapies for Migraine Prevention: Lifestyle Changes

ByJessica Ailani, MD,Christopher Gottschalk, MD,Andrew C. Charles, MD,Rebecca Erwin Wells, MD, MPH,Stephanie J. Nahas, MD

December 3rd 2021

Rebecca Erwin Wells, MD, MPH, details the effectiveness of lifestyle changes for preventative migraine treatment.

Goals of Preventative Therapy for Migraine

ByJessica Ailani, MD,Andrew C. Charles, MD,Stephanie J. Nahas, MD,Christopher Gottschalk, MD,Rebecca Erwin Wells, MD, MPH

November 19th 2021

Expert neurologists share their goals and patient considerations for preventive migraine therapy.

Migraine: A Historic Perspective on Preventative Therapy

ByJessica Ailani, MD,Stephanie J. Nahas, MD,Christopher Gottschalk, MD,Andrew C. Charles, MD,Rebecca Erwin Wells, MD, MPH

November 19th 2021

Andrew C. Charles, MD, provides a historical perspective on the agents traditionally used for preventive migraine therapy.

Determining Migraine Treatment Eligibility: Stephanie J. Nahas, MD

ByStephanie J. Nahas, MD

May 27th 2021

The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed the role of clinicians in determining migraine treatment eligibility.

Underutilization of Preventive Migraine Treatments: Stephanie J. Nahas, MD

ByStephanie J. Nahas, MD

May 21st 2021

The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed the barriers to the use of preventive medicines.

Optimizing Treatment in Acute Migraine: Stephanie J. Nahas, MD

ByStephanie J. Nahas, MD

May 7th 2021

The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University detailed the ways clinicians can tailor their treatment regimens better.

Advantages of Fremanezumab Among CGRP Migraine Agents: Stephanie J. Nahas, MD

ByStephanie J. Nahas, MD

April 23rd 2021

The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University detailed the reasons fremanezumab stands out among a crowded migraine treatment landscape.

Efficacy and Safety of Fremanezumab Further Displayed: Stephanie J. Nahas, MD

ByStephanie J. Nahas, MD

April 19th 2021

The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed 2 research projects she led presented at AAN 2021 on the efficacy and safety of fremanezumab.